MedPage Today (April 2, 2014): Non-Amyloid Targets for Drug Development

Publication Date: 
Wed, 04/02/2014

What non-amyloid targets should be pursued for Alzheimer's disease therapies? We put the question to three well-known researchers in the field: Bradley Hyman, MD, PhD, of Massachusetts General Hospital in Boston; John Trojanowski, MD, PhD, of the University of Pennsylvania in Philadelphia; and Richard J. Caselli, MD, of the Mayo Clinic in Scottsdale, Ariz.

Their answers ranged from tau protein pathologies to apolipoprotein E to general neuroprotection.

www.medpagetoday.com/HOTTOPICSNeurology/Neurology-Videos/443